Rare diseases
Investigational molecules
Locations
5858 Horton Street, 94608-2006, United States
The sponsor is actively engaged in developing advanced gene therapy solutions for inherited retinal diseases. Their research portfolio focuses on addressing genetic mutations that lead to progressive vision loss and blindness. The company's therapeutic approach targets specific genetic disorders of the retina through innovative molecular interventions designed to restore or preserve visual function in affected patients.
The sponsor's work emphasizes the development of targeted therapies for rare ophthalmic genetic conditions that currently have limited treatment options. Their research aims to address the underlying molecular causes of vision impairment through precision medicine approaches, focusing on conditions that affect the photoreceptor cells and retinal structure.
4d Molecular Therapeutics Inc. runs clinical trials in conditions such as Neovascular age-related macular degeneration, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
